USE OF SEMAPHORIN 3A FOR DIAGNOSING AND TREATING CANCER, ESPECIALLY PROSTATE CANCER

Details for Australian Patent Application No. 2002231874 (hide)

Owner UROGENE SOCIETE ANONYME

Inventors CUSSENOT, Olivier; ALGARTEGENIN, Michele; LATIL, Alain

Pub. Number AU-A-2002231874

PCT Pub. Number WO2002/086157

Priority 60/284,508 19.04.01 FR

Filing date 11 January 2002

Wipo publication date 5 November 2002

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-A-2002231874

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002231875-SYSTEM FOR SPORTING BETTING BASED ON THE MARKET PRINCIPLE AND USING A TELECOMMUNICA- TION NETWORK AND COMPUTER FOR OPERATION OF SAID SYSTEM

2002231873-SYNTHETIC OR METAL ROOT GROUTING